Jove
Visualize
Contact Us

Related Experiment Videos

Interferon DNA polymorphism in chronic leukemia

E Rozenblum1, I Larripa, L Barazzutti

  • 1BioSidus Laboratory, Sanatorio Guemes, Buenos Aires, Argentina.

Leukemia & Lymphoma
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia.

Gene·2019
Same author

Identification of driver and subclonal mutations in ASXL1 and IDH1/IDH2 genes in an Argentine series of patients with myelofibrosis.

International journal of laboratory hematology·2018
Same author

Clinical experience with moroctocog alfa (AF-CC) in younger paediatric patients with severe haemophilia A: Two open-label studies.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation.

Bone marrow transplantation·2017
Same author

Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators.

Leukemia·2016
Same author

Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same journal

Glofitamab for the treatment of relapsed/refractory hairy cell leukemia: a case report.

Leukemia & lymphoma·2026
Same journal

Pre- and post-transplant serum albumin levels and outcomes after allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia.

Leukemia & lymphoma·2026
Same journal

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

Leukemia & lymphoma·2026
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

This study investigated interferon (IFN) gene differences in chronic leukemia patients. Genetic variations in interferon-beta were found in chronic myeloid leukemia patients compared to healthy individuals.

Area of Science:

  • Immunology
  • Genetics
  • Oncology

Background:

  • The interferon (IFN) system is crucial for antiviral and antitumor immunity.
  • Exogenous IFN therapy shows variable efficacy in chronic leukemias like HCL and CML.
  • Previous research indicates potential for IFN-alpha therapy to induce remission.

Purpose of the Study:

  • To investigate genetic differences in interferon-alpha and beta genes.
  • To compare gene variations between healthy individuals and patients with chronic leukemias (HCL, CML, CLL).
  • To identify potential genetic markers associated with chronic leukemias.

Main Methods:

  • Restriction fragment length polymorphism (RFLP) analysis was employed.
  • A panel of patients with HCL, CML, and CLL was studied.

Related Experiment Videos

  • A control group of healthy individuals was included for comparison.

    • Main Results:

    • Significant differences in allelic frequencies for the IFN-beta gene were observed.
    • These differences were particularly noted with the Sst I enzyme.
    • Variations were most prominent in chronic leukemias of myeloid origin when compared to healthy controls.

    Conclusions:

    • Genetic variations in the interferon-beta gene are associated with chronic leukemias, especially myeloid types.
    • RFLP analysis can identify differences in IFN genes between leukemic patients and healthy individuals.
    • These findings may contribute to understanding leukemia pathogenesis and developing targeted therapies.